Dimitri Boiroux

Dr. Dimitri Boiroux


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Control Engineering Practice
Verified
Journal Article
Closed access
DBDimitri Boiroux
Dimitri Boiroux
ADAnne Katrine Duun-Henriksen
Anne Katrine Duun-Henriksen
SSSigne Schmidt
Signe Schmidt
KNKirsten Nørgaard
Kirsten Nørgaard
NPNiels Kjølstad Poulsen
Niels Kjølstad Poulsen
JJJohn Bagterp Jørgensen
John Bagterp Jørgensen

1 January 2018 in Biomedical Signal Processing and Control
Verified
Journal Article
Closed access
DBDimitri Boiroux
Dimitri Boiroux
ADAnne Katrine Duun-Henriksen
Anne Katrine Duun-Henriksen
SSSigne Schmidt
Signe Schmidt
KNKirsten Nørgaard
Kirsten Nørgaard
SMSten Madsbad
Sten Madsbad
JJJohn Bagterp Jørgensen
John Bagterp Jørgensen

1 August 2018 in Journal of Process Control
Verified
Journal Article
Closed access
DBDimitri Boiroux
Dimitri Boiroux
VBVladimír Bátora
Vladimír Bátora
MHMorten Hagdrup
Morten Hagdrup
SWSabrina Lyngbye Wendt
Sabrina Lyngbye Wendt
NPNiels Kjølstad Poulsen
Niels Kjølstad Poulsen
JJJohn Bagterp Jørgensen
John Bagterp Jørgensen

1 August 2019 in Journal of Process Control
Verified
Journal Article
Closed access
JGJose Garcia-Tirado
Jose Garcia-Tirado
JCJohn P. Corbett
John P. Corbett
DBDimitri Boiroux
Dimitri Boiroux
JJJohn Bagterp Jørgensen
John Bagterp Jørgensen
MBMarc D. Breton
Marc D. Breton

25 September 2016 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
DBDimitri Boiroux
Dimitri Boiroux
TATinna Björk Aradóttir
Tinna Björk Aradóttir
KNKirsten Nørgaard
Kirsten Nørgaard
NPNiels Kjølstad Poulsen
Niels Kjølstad Poulsen
HMHenrik Madsen
Henrik Madsen
JJJohn Bagterp Jørgensen
John Bagterp Jørgensen
Bolus calculators help patients with type 1 diabetes to mitigate the effect of meals on their blood glucose by administering a large amount of insulin at mealtime. Intraindividual changes in patients physiology and nonlinearity in insulin-glucose dynamics pose a challenge to the accuracy of such calculators. We propose a method based on a continuous-discrete unscented Kalman filter to continuously track the postprandial glucose dynamics and the insulin sensitivity. We augment the Medtronic Virtual Patient (MVP) model to simulate noise-corrupted data from a continuous glucose monitor (CGM). The basal rate is determined by calculating the steady state of the model and is adjusted once a day before breakfast. The bolus size is determined by optimizing the postprandial glucose values based on an estimate of the insulin sensitivity and states, as well as the announced meal size. Following meal announcements, the meal compartment and the meal time constant are estimated, otherwise insulin sensitivity is estimated. We compare the performance of a conventional linear bolus calculator with the proposed bolus calculator. The proposed basal-bolus calculator significantly improves the time spent in glucose target (P < .01) compared to the conventional bolus calculator. An adaptive nonlinear basal-bolus calculator can efficiently compensate for physiological changes. Further clinical studies will be needed to validate the results.

1 September 2013 in Journal of Diabetes Science and Technology
Verified
Journal Article
Open access
PDF file
SSSigne Schmidt
Signe Schmidt
DBDimitri Boiroux
Dimitri Boiroux
ADAnne Katrine Duun-Henriksen
Anne Katrine Duun-Henriksen
LFLaurits Frøssing
Laurits Frøssing
OSOle Skyggebjerg
Ole Skyggebjerg
KNKirsten Nørgaard
Kirsten Nørgaard
Background: To improve type 1 diabetes mellitus (T1DM) management, we developed a model predictive control (MPC) algorithm for closed-loop (CL) glucose control based on a linear second-order deterministic-stochastic model. The deterministic part of the model is specified by three patient-specific parameters: Insulin sensitivity factor, insulin action time, and basal insulin infusion rate. The stochastic part is identical for all patients but identified from data from a single patient. Results of the first clinical feasibility test of the algorithm are presented. Methods: We conducted two randomized crossover studies. Study 1 compared CL with open-loop (OL) control. Study 2 compared glucose control after CL initiation in the euglycemic (CL-Eu) and hyperglycemic (CL-Hyper) ranges, respectively. Patients were studied from 22:00–07:00 on two separate nights. Results: Each study included six T1DM patients (hemoglobin A1c 7.2% ± 0.4%). In study 1, hypoglycemic events (plasma glucose < 54 mg/dl) occurred on two OL and one CL nights. Average glucose from 22:00–07:00 was 90 mg/dl [74–146 mg/dl; median (interquartile range)] during OL and 108 mg/dl (101–128 mg/dl) during CL (determined by continuous glucose monitoring). However, median time spent in the range 70–144 mg/dl was 67.9% (3.0–73.3%) during OL and 80.8% (70.5–89.7%) during CL. In study 2, there was one episode of hypoglycemia with plasma glucose <54 mg/dl in a CL-Eu night. Mean glucose from 22:00–07:00 and time spent in the range 70–144 mg/dl were 121 mg/dl (117–133 mg/dl) and 69.0% (30.7–77.9%) in CL-Eu and 149 mg/dl (140–193 mg/dl) and 48.2% (34.9–72.5%) in CL-Hyper, respectively. Conclusions: This study suggests that our novel MPC algorithm can safely and effectively control glucose overnight, also when CL control is initiated during hyperglycemia.